Skip to main content
AI Market Summary
Loading market intelligence...

TESARO, Inc. (TSRO) Stock Forecast 2025 - AI Price Prediction & Analysis


TESARO, Inc. (TSRO) AI Stock Price Forecast & Investment Analysis

TESARO, Inc. Stock Price Chart and Technical Analysis

Loading TESARO, Inc. interactive price chart and technical analysis...

TESARO, Inc. (TSRO) - Comprehensive Stock Analysis & Investment Research

Deep dive into TESARO, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about TESARO, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For TESARO, Inc.: TESARO, Inc. operates in the Health Technology sector, establishing it as a mid-cap growth opportunity.

TESARO, Inc. (Stock Symbol: TSRO) is a leading company in the Health Technology sector , specifically operating within the Biotechnology industry.

The organization employs approximately 715 professionals worldwide and operates under the strategic leadership of CEO Leon O. Moulder.

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing TESARO, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TESARO, Inc.: With $219M in annual revenue and -295.7% net margin, the company demonstrates developing profitability.

Annual Revenue: $219 million generating a -295.7% net profit margin .

Market Capitalization: $4123 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -469.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for TESARO, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For TESARO, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for TESARO, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: TESARO, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For TESARO, Inc.: Market positioning analysis based on available financial and operational metrics.

TESARO, Inc. strategically competes in the highly dynamic Biotechnology marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 66.4% gross margin, indicating strong pricing power and operational efficiency.

TESARO, Inc. (TSRO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for TESARO, Inc. stock analysis.

Loading TESARO, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into TESARO, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if TESARO, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For TESARO, Inc.: With a P/E ratio of -6.32, the market sees the stock as potentially undervalued.

P/E Ratio -6.32x
P/B Ratio -31.50x
Market Cap $4123M
EPS $-11.86
Book Value/Share $-2.38
Revenue/Share $3.98
FCF/Share $-7.17
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently TESARO, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For TESARO, Inc.: An ROE of -469.1% indicates room for improvement in shareholder value creation.

ROE -469.1%
ROA -92.9%
ROIC -116.4%
Gross Margin 66.4%
Operating Margin -283.3%
Net Margin -295.7%
EBT Margin -294.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess TESARO, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For TESARO, Inc.: A current ratio of 3.40 indicates strong liquidity.

Current Ratio 3.40x
Quick Ratio 2.67x
D/E Ratio 1.75x
Financial Leverage 3.46x
Interest Coverage -12.0x
Working Capital $622M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal TESARO, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For TESARO, Inc.: Free cash flow of $-573M indicates cash challenges that need attention.

Operating Cash Flow $-551M
Free Cash Flow $-573M
Capital Spending $-22M
FCF/Sales -261.3%
CapEx/Sales 10.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively TESARO, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For TESARO, Inc.: An asset turnover of 0.31x suggests room for improvement in asset utilization.

Asset Turnover 0.31x
Receivables Turnover 7.4x
Inventory Turnover 0.9x
Fixed Assets Turnover 22.2x
Days Sales Outstanding 49 days
Days Inventory 395 days
Payables Period 85 days
Cash Conversion Cycle 359 days
Understanding Financial Statement Data

What these metrics mean: Key figures from TESARO, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For TESARO, Inc.: With annual revenue of $219M, TESARO, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $219M
Operating Income $-621M
Net Income $-649M
R&D Expense $178M
SG&A Expense $172M
Cost of Goods Sold $34M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 91%
Cash & Short-term Investments 67%
Total Liabilities 118%
Accounts Receivable 4%
Inventory 15%
Dividend & Shareholder Information
Shares Outstanding 55M

Latest TESARO, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting TESARO, Inc. (TSRO) stock price and investment outlook.

, source: Fox Business

Following news of apublic offering of 1.75 million shares of its common stock, shares inTesaro, Inc. (NASDAQ: TSRO) are slipping 10.7% at 3:30 p.m. EST Tuesday. Ahead of an FDA decision next year on ...

, source: Law

Tesaro, a pharmaceutical company based in Massachusetts, sued AnaptysBio Inc. on Nov. 20 in Delaware Court of Chancery. The lawsuit, which is not publicly available, was brought by Ross Aronstam & ...

, source: Fox Business

What: After reporting success in a phase 3 ovarian cancer trial at the end of June, shares in Tesaro, Inc. (NASDAQ: TSRO) spiked 15% in July,according toS&P Global Market Intelligence. So what:Tesaro ...

, source: Nasdaq

Shares of Tesaro, Inc. (NASDAQ: TSRO) were down 10.8% as of 3:38 p.m. EDT on Monday. The decline appeared to be related to two developments. One was that analysts at investment bank Cowen reaffirmed ...

, source: The Motley Fool

A canceled appearance fuels hope that the troubled biotech finally has found a buyer. Shares of Tesaro, Inc. (NASDAQ: TSRO), an oncology-focused biopharma company, are rising again in response to ...

, source: Nasdaq

Shares of Tesaro (NASDAQ: TSRO) dropped 13.8% on Wednesday, as the biotech continues to struggle from the data onslaught at the European Society for Medical Oncology (ESMO) Congress. All told, Tesaro ...

, source: The Motley Fool

Good news for a rival drug translates to bad news for Tesaro. Shares of Tesaro, Inc. (NASDAQ: TSRO) were down 10.8% as of 3:38 p.m. EDT on Monday. The decline appeared to be related to two ...

TESARO, Inc. Competitors & Peer Analysis - Health Technology Sector

Comparative analysis of TESARO, Inc. against industry peers and competitors in the Health Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - TESARO, Inc. Stock Forecast

How accurate are TESARO, Inc. stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for TSRO predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence TESARO, Inc. stock price forecasts?

Our analysis considers TESARO, Inc.'s financial metrics, Health Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is TESARO, Inc. a good investment in 2025?

Based on our AI analysis, TESARO, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are TESARO, Inc. forecasts updated?

TESARO, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced TESARO, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for TESARO, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...